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Transglycosylation activityThe Bacillus circulans ATCC 31382 b-galactosidase (BgaD) is a retaining-type glycosidase of glycoside
hydrolase family 2 (GH2). Its commercial enzyme preparation, Biolacta N5, is used for commercial-
scale production of galacto-oligosaccharides (GOS). The BgaD active site and catalytic amino acid
residues have not been studied. Using bioinformatic routines we identiﬁed two putative catalytic
glutamates and two highly conserved active site histidines. The site-directed mutants E447N,
E532Q, and H345F, H379F had lost (almost) all catalytic activity. This conﬁrmed their essential role
in catalysis, as general acid/base catalyst (E447) and nucleophile (E532), and as transition state sta-
bilizers (H345, H379), respectively.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The b-galactosidase of Bacillus circulans ATCC 31382 (BgaD)
belongs to the family 2 of glycoside hydrolases (GH2) [1,2]; its phys-
iological role is to hydrolyze lactose into galactose and glucose. Its
commercial preparation Biolacta N5 has 4 C-terminally truncated
active isoforms, products of proteolysis. Recently, we have cloned
the B. circulans bgaD gene and characterized the four similar recom-
binant isoforms rBgaD-(A-D) and the four Biolacta N5 puriﬁed
isoforms b-GalA-D. The results showed that the smallest isoforms
b-Gal-D and rBgaD-D have the same GOS product proﬁles as the
longer and full-length proteins [3]. The GH2 family members have
an active site which is composed of two catalytic residues: a cata-
lytic nucleophile and a general acid/base catalyst. GH2 family
enzymes are b-retaining and employ a double displacement mech-
anism (Fig. 1). First, the catalytic nucleophile attacks the anomeric
center of the sugar, generating the galactosyl–enzyme intermedi-
ate. Subsequently, this intermediate undergoes hydrolysis or trans-
glycosylation. Both steps require assistance of a general acid/basecatalyst [4]. At high lactose concentrations some b-galactosidases
switch from a hydrolytic to a syntheticmechanismwhereby lactose
(instead of water) acts as acceptor for the covalently bound galact-
ose [5]. The newly formed product is a galacto-oligosaccharide
(GOS).
The B. circulans b-galactosidase (monomeric protein, 1737 amino
acids, metal independent, catalytic residues unknown [6]) has high
transgalactosylation activity and is applied at industrial scale to
produce GOS [6,7]. The enzyme shares 22% sequence identity with
the Escherichia coli b-galactosidase (tetrahomomeric protein, 1024
amino acids, metal-ion dependent, 2 Glu catalytic residues) which
has been well characterized [8–15]. Whereas the B. circulans b-
galactosidase activity is metal independent [6], the E. coli b-galacto-
sidase requires bothMg2+ and Na+ for maximal activity: the sodium
ion directly ligands the lactose 6-hydroxyl and the magnesium ion
may contribute to the role of the general acid/base catalyst [16].
In contrast to B. circulans b-galactosidase, the E. coli enzyme is a poor
producer of GOS [16]. In the E. coli b-galactosidase enzyme the
amino acid residues E461 and E537 are respectively the catalytic
proton donor and the nucleophile [14]. Moreover, residue H358
was identiﬁed as a transition state stabilizer following the observa-
tion that it forms strong hydrogen bonds with the C30 hydroxyl
group of the galactosyl unit [10]. Another study showed that the
nitrogen of residue H392 is within H-bonding distance of the C30
hydroxyl group of the galactosyl unit and thereby promotes
1016 J.B. Bultema et al. / FEBS Open Bio 4 (2014) 1015–1020catalysis by stabilizing the transition state [9]. Here we character-
ized site-directed mutants of the two putative catalytic glutamates
in B. circulans b-galactosidase and two conserved histidines in the
active site. This is the ﬁrst report on mutagenesis of the putative
Glu catalytic residues of B. circulans b-galactosidase, showing
that a change in these residues results in loss of b-galactosidase
activity.
2. Materials and methods
2.1. General
B. circulans ATCC 31382, obtained from LGC Standards (Wesel,
Germany), was grown at 30 C in 3% (w/v) beef extract and 5%
(w/v) peptone. E. coli strain TOP10F (Invitrogen, Carlsbad, CA)
was used for cloning purposes and grown at 37 C in Luria–Bertani
medium. For plasmid selection the appropriate antibiotic was
added at the following concentrations: 50 lg ml1 for kanamycin
and 100 lg ml1 for ampicillin. E. coli BL21 (DE3) grown at 30 C
was used for high-level expression of b-galactosidases of strain
ATCC 31382. Plasmids pZErO-2 and pET15b (both Invitrogen) were
used for cloning and expression purposes, respectively. Protein
concentrations were determined using the Bradford reagent (Bio-
Rad, Munich, Germany) with bovine serum albumin as standard.
2.2. DNA preparation and manipulation
Genomic DNA of B. circulans ATCC 31382 was isolated from an
overnight grown nutrient broth culture using the GenElute Bacte-
rial Genomic DNA kit (Sigma) according to the recommendations
of the manufacturer. Preparation of plasmid DNA cultures of E. coli
was performed using the GenElute Plasmid Miniprep Kit (Sigma)
according to the recommendations of the manufacturer. DNA
restriction, ligations, and transformation were performed accord-
ing to protocols described by Sambrook et al. [17].Fig. 1. Reaction mechanisms of the B. circulans b-galactosidase enzyme, also showing the
as nucleophile. Residue H345 forms strong hydrogen bonds with the C30 hydroxyl group o
is within H-bonding distance of the C30 hydroxyl group of the galactosyl unit and thereb
(A) Hydrolysis reaction, using water as acceptor substrate. (B) Transglycosylation reactio
displacement mechanism and use lactose as donor substrates. The glycosidic linkage in la
nucleophile in the active site. A subsequent reaction with water as acceptor substrate re
acceptor substrate as well, resulting in release of oligosaccharide products (B: transglyc2.3. PCR ampliﬁcation
PCRwasperformedwith genomicDNAofB. circulansATCC31382
as template to prepare theDNA fragment that correspond to isoform
b-Gal-Das found inBiolactaN5using the commonsenseprimer sup-
plemented by the NcoI restriction enzyme site (50-TATACCATGG
GAAACAGTGTGAGCTATGATGG-30) and anti-sense primer by the
BglII site (rBgaD-D, 50-TTTAGATCTTTATGGCGTTACACGTAAATAC-
30). The obtained PCR product was puriﬁed using the GenElute PCR
Clean-Up Kit (Sigma), and blunt ligated into the EcoRV site of pZE-
rO-2 followed by a digestion with NcoI and BglII and separated with
agarose gel electrophoresis. DNA fragment with the right size was
cut out, puriﬁed with the GenElute Gel Extraction Kit (Sigma) and
ligated into pET-15b to prepare expression plasmid pET-15b-
rBgaD-D.
2.4. Bioinformatic analyses
Using T-Coffee [3,18], the B. circulans rBgaD-D amino acid
sequencewas alignedwith seven other family GH2 b-galactosidases
(Table 1). This alignment was improved manually with Jalview 2.8
[19] by careful examination with Pymol of a 3D BgaD (a.a. 50–650)
model queried using PHYRE [20] which was structurally aligned
with crystal structures of Kluyveromyces lactis BgaL, E. coli LacZ and
Arthrobacter sp. C2-3 LacZ.
2.5. Site-directed mutagenesis
Site-directed mutagenesis of the B. circulans rbgaD-D gene was
carried out with the QuikChange™ site directed mutagenesis kit
(Stratagene) and conﬁrmed by sequencing. Pfu TurboDNA polymer-
ase (Stratagene) was used for all polymerase chain reactions (PCR)
(95 C, 30 s; 55 C, 1 min; 68 C, 10 min for 30 cycles) using plasmid
pET15b-rBgaD-D as template [3]. PCR products were digested
with DpnI to speciﬁcally digest the DNA templates. Subsequently,catalytic glutamate residues involved, namely E447 as acid/base catalyst, and E532
f the galactosyl unit and stabilizes the transition state. The nitrogen of residue H379
y promotes catalysis by stabilizing the transition state (not visualized in the ﬁgure).
n, using lactose as acceptor substrate. Both reactions proceed according to a double-
ctose is cleaved, resulting in glucose release and covalent binding of galactose to the
sults in release of galactose as well (A: hydrolysis). Alternatively, lactose is used as
osylation).
Table 1
Comparison of the b-galactosidase amino acid sequences of Bacillus circulans ATCC 31382 with other b-galactosidases.
Enzyme source Enzyme name No. a.a.a Identity (%) Similarity (%) Uniprot code PDB codeb
Bacillus circulans ATCC 31382 BgaD-A 1737 100 100 E5RWQ2
Biﬁdobacterium biﬁdum DSM 20215 BIF3 1752 28 43 Q9F4D5
Biﬁdobacterium biﬁdum NCIMB 41171 BbgIII 1935 29 42 A4K5H9
Biﬁdobacterium biﬁdum NCIMB 41171 BbgI 1291 14 24 E4V7B8
Biﬁdobacterium biﬁdum NCIMB 41171 BbgIV 1052 13 23 Q0ZII7
Kluyveromyces lactis CBS2359 BgaL 1025 13 22 P00723 3OB8
Escherichia coli K12 LacZ 1024 13 22 P00722 1DP0
Arthrobacter sp. C2-2 LacZ 1023 13 25 Q8KRF6 1YQ2
a Number of amino acids.
b PDB codes used for structural alignment with the 3D model of the rBgaD-cat (a.a. 50–650).
Fig. 2. Overlay of the protein model for B. circulans rBgaD-50–650 in yellow and
E.coli b-galactosidase crystal structure (PDB: 1DP0) in blue. The two catalytic
glutamates (E477, E532) and two conserved histidines (H345, H397) are shown for
B. circulans rBgaD-50–650. The magnesium (magenta) and sodium (light blue) ions
are required for E.coli b-galactosidase, but not for the b-galactosidase of B. circulans.
(For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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coli BL21 (DE3) competent cells. For site-directed mutagenesis the
following oligonucleotides were used in PCR reactions: 50-CACG
GCGTTTCGATGTTCCATGATTTAGGGG-30 (H345F); 50-CC ATCAGGGT
TACCTTCAACCCGGCATCAC-30 (H379F); 50-ATCATG TG GTCGATCGG
AAATAACATATATGATACGACCAATGCC-30 (E447N) and 50-CTGTAC
GGCTCGCAGACGTCCTCGG-30 (E532Q).
2.6. Recombinant protein expression and puriﬁcation
E. coli expression of the b-galactosidase rBgaD-D and the four
mutants were inducedwith 0.5 mM isopropyl-b-D-thiogalactopyra-
noside (IPTG) (Thermo) at an optical cell density at 600 nmof 0.6 for
4 h at 30 C. Cells were harvested, washedwith 20 mMTris–HCl (pH
7.5) (Buffer A) and resuspended in B-PER lysis solution (Thermo).
After 10 min incubation at room temperature, cell debris was
removed by a centrifugation step and cell free extract with rBgaD-
D was loaded on a HiTrap Q 1 ml column (Pharmacia) which was
equilibrated with Buffer A. The ﬂow through with rBgaD-D or oneof the four mutants was collected, concentrated with an ultraﬁltra-
tion device (Centricon Plus-20 with 50 kDa molecular cutoff, Milli-
pore, Bedford, MA) and loaded on HiTrap Q 1 ml column
(Pharmacia) whichwas equilibratedwith Buffer B (20 mMN-Cyclo-
hexyl-2-aminoethanesulfonic acid (CHES), pH 9.5) and unbound
proteins were washed away with 5 column volumes of Buffer B.
The elutionwas carried outwith 20 ml of linear salt gradient to Buf-
fer C (1 M NaCl in Buffer B). Fractions of 0.5 ml were collected and
analyzed by 8% SDS–PAGE. Recombinant protein containing frac-
tions were pooled and concentrated with an ultraﬁltration device
(Centricon Plus-20with 50 kDamolecular cutoff,Millipore, Bedford,
MA), loaded on a Superdex 200 column equilibrated with Buffer D
(150 mM NaCl in Buffer A), and fractions of 0.5 ml were collected.
Fractionswith rBgaD-Dor one of the fourmutantswere pooled, con-
centrated if necessary, and protein concentrationswere determined
as described.
2.7. Activity measurements
The speciﬁc activity of puriﬁed (mutant) b-galactosidase
enzymes toward lactose was measured by following enzymatically
released glucose with the glucose oxidase/peroxidase method
(Megazyme). One enzyme activity unit is deﬁned as the amount of
enzyme in mg required for the hydrolysis of 1 lmol lactose per
min at 40 C and pH 6.0.
To determine kinetic parameters of (mutant) b-galactosidase,
initial reaction rates for the hydrolysis of ortho-nitrophenyl-b-
galactoside (o-NPG) with a molar extinction coefﬁcient of
4500 M1 cm1 at 420 nm were determined spectrophotometri-
cally (420 nm) at 40 C and pH 6.0 over a concentration range of
1–38 mM. To prepare the substrate solutions, o-NPG was dissolved
in 0.1 M phosphate buffer (pH 6.0) by heating and subsequently
kept at 40 C to prevent precipitation. The reaction was initiated
by adding 10 ll of enzyme solution to 190 ll substrate solutions.
The Vmax, kcat and KM values, expressed as the mean ± SD of values
obtained by triplicate measurements, were determined from
Lineweaver–Burk (LB) plots in case of rBgaD-D and mutant E532Q.
2.8. Thermal shift assay
The melting temperature (Tm) (temperature at which 50% of the
protein is unfolded) of rGalD-D and the four mutants derived were
determined by a ﬂuorescence-based thermal shift assay [21]. Solu-
tions of 5 ll of 250  SYPRO Orange (Molecular Probes), 2.5 ll of
1 Macetate buffer, pH6.0, 12.5 ll ofMilli-Q and5 ll of 1 mg/ml pro-
tein were mixed, and heated from 25 C to 95 C in increments of
0.5 C/min on a CFX96 real-time system-C1000 Thermal Cycler
(Bio-Rad). All measurements were done in triplicate. SYPRO Orange
dye interacts with a protein undergoing thermal unfolding, with its
ﬂuorescence increasing upon exposure to the protein’s hydrophobic
core. The TM for rGalD-D and the four mutants were determined by
Fig. 3. Multiple sequence alignment (created using T-Coffee and Jalview 2.8) of beta-galactosidase proteins, revealing four conserved blocks. The ﬁrst two blocks contain the
conserved histidine residues and the last two blocks contain the conserved and (putative catalytic) glutamate residues (boxed in grey). Asterisks indicate fully conserved
residues. Residues subjected to mutagenesis are shown in bold [9,10,14,22]. BgaD_Bacci, B. circulans ATCC 31382 BgaD; BIF3_Bifbi, Biﬁdobacterium biﬁdum DSM 20215 BIF3;
BbgIII_Bifbi, Biﬁdobacterium biﬁdum NCIMB 41171 BbgIII; BbgI_Bifbi, Biﬁdobacterium biﬁdum NCIMB 41171 BbgI; BbgIV_Bifbi, Biﬁdobacterium biﬁdum NCIMB 41171 BbgIV;
BgaL_Klula, Kluyveromyces lactis CBS2359 BgaL; LacZ_Escco, Escherichia coli K12 LacZ; LacZ_Arthr, Arthrobacter sp. C2–2 LacZ.
Table 2
Kinetic parameters for the Bacillus circulans ATCC 31382 b-galactosidase rGalD-D and
the E532Q site-directed mutant.a All parameters were determined at 40 C and pH
6.0. One enzyme activity unit is deﬁned as the amount of enzyme in mg required for
the hydrolysis of 1 lmol lactose per min at 40 C and pH 6.0. Hydrolysis of oNPG (oNP
release at 420 nm) was used to determine the kinetic parameters Vmax (lmol min1 -
mg1 of protein), KM (mM) and kcat (s1). Subscripts high and low indicate parameters
determined from the high and low substrate regions in biphasic Lineweaver–Burk
plots, respectively. All measurements were done in triplo.
Enzyme rGalD-D E532Q
Lactose hydrolysis units min1 mg1 158.5 ± 5.4 0.47 ± 0.02
oNPG hydrolysis kinetic parameters
Vmax,high 277.7 ± 2.7 1.0 ± 0.1
Km,high 45.9 ± 2.7 43.6 ± 0.1
kcat,high 424.1 ± 4.1 1.6 ± 0.1
Vmax,low 35.8 ± 9.3 0.2 ± 0.01
Km,low 1.5 ± 0.9 1.9 ± 0.3
kcat,low 56.3 ± 11.9 0.2 ± 0.01
a H379F, H345F and E447N site-directed mutants were inactive.
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manager 2.0 software (Bio-Rad).
3. Results and discussion
3.1. Alignment and structural modeling
The active site of b-galactosidase (LacZ) of E. coli is structurally
and biochemically well characterized [8–15]. The amino acid resi-
dues E461 and E537 were identiﬁed as respectively the general
acid/base catalyst and the nucleophile. Mutations in these residues,
introducing several different residues at these positions, resulted in
loss of activity [14,22]. Moreover, residues H357 and H540 were
identiﬁed as being important for stabilization of the transition state.
Mutations in these residues, introducing several different residues
at these positions, also resulted in loss of activity [9,10]. Currently,
no such information is available about the active site of B. circulans
b-galactosidase rBgaD enzyme.
A protein sequence alignment was made between B. circulans b-
galactosidase rBgaD and other b-galactosidases known to be pro-
ducers of GOS (Table 1). The highest sequence identity was found
with the BIF3 and BbgIII enzymes of Biﬁdobacterium biﬁdum DSM
20215 and B. biﬁdum NCIMB 41171, respectively (Table 1). How-
ever, also their active site residues have not been identiﬁed and
characterized yet. The catalytic residues of b-galactosidases of K.
lactis, E. coli and Arthrobacter sp. C2-2 were previously identiﬁed
but their sequence identity (Table 1) was too low for identiﬁcation
of the catalytic residues of B. circulans b-galactosidase. To improve
this protein sequence alignment, a 3D protein model was predicted
for the catalytic domain of B. circulans rBgaD-50–650 (a.a.) and
structurally aligned with crystal structures of K. lactis BgaL, E. coli
LacZ and Arthrobacter sp. C2-2 LacZ (Fig. 2). Manual adjustmentsbased on the structural alignment were made and enabled the
identiﬁcation of the rBgaD-D conserved residues E447 and E532
as the putative general acid/base catalyst and the nucleophile,
respectively. The two histidines in E. coli LacZ identiﬁed as being
important for stabilization of the transition state were also con-
served in B. circulans with H345 and H379 as their equivalents.
Moreover, two conserved glutamates, the putative general acid/
base catalyst and the nucleophile for B. biﬁdum DSM 20215 BIF3
(E479 and E567), B. biﬁdum NCIMB 41171 BbgI, BbgIII and BbgIV
(E589 and E681, E479 and E567, E490 and E564, respectively)
which have not been reported before, were identiﬁed as well
(Fig. 3).
3.2. Characterization of site-directed mutants
B. circulans b-galactosidase residues H345, H379, E447 and E532
were changed by site-directed mutagenesis. The activity of the
puriﬁed enzymes with lactose was determined by measuring glu-
cose release. Three mutants (H345F, H379F and E447N) were inac-
tive with the assay used, whereas the activity of mutant E532Q
was reduced at least 340-fold compared to the wild type enzyme
(Table 2). This is the ﬁrst report on mutagenesis of these residues
of the B. circulans ATCC 31382 b-galactosidase, showing that when
they are changed, enzyme activity is lost (virtually) completely.
Kinetic properties could only be determined for wild type and
site-directed mutant E532Q (Table 2). Both wild type and E532Q
mutant showed biphasic Lineweaver–Burk (LB) plots for which
kinetic parameters could be determined separately. This resulted
in two sets of kinetic parameters (Vmax, KM and kcat): one for the
lower and one for the higher substrate concentration regions, sim-
ilar to what was shown previously for rGalD-D [3]. Such biphasic
LB plots have been reported for hydrolytic enzymes that show
transglycosylation activity at higher substrate concentrations
[2,6]. The kcat,high for the E532Q mutant had decreased 270-fold,
with an almost unchanged Km,high. A decreased kcat,low value
(250-fold) also was determined for the E532Q mutant, whereas
its Km,low increased about 30% (from 1.5 to 1.9 mM). The assay sen-
sitivity could not be increased enough to determine kinetic param-
eters for the three other mutants.
On basis of this data we conclude that E447 and E532 of B. cir-
culans b-galactosidase act as general acid/base catalyst and nucle-
ophile, respectively. The data also shows that H345 and H379 are
essential for activity of the B. circulans b-galactosidase. This
strongly suggests that these two residues are important for transi-
tion state stabilization as was shown for the similar residues in the
E. coli b-galactosidase [9,10].
3.3. Melting temperatures (Tm) determined with the thermal shift
assay
Mutations in the catalytic residues and two histidines of the
E. coli b-galactosidase caused minor, if any, structural changes in
Fig. 4. (Top) Melting curves showing protein unfolding by increasing temperatures, accompanied by increase in SYPRO Orange ﬂuorescence. The melting temperature (Tm)
values were determined by calculating the ﬁrst derivative from the melting curve with CFX manager 2.0 software (Bio-Rad). (Bottom) The X-axis value (T) that corresponds
with the lowest Y-axis value (d(RFU)/dT) in the resulting curve resembles Tm. In the case of E532Q two melting temperatures were found.
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catalytic residues and two histidines of the B. circulans ATCC
31382 b-galactosidase had caused structural changes; we recorded
protein melting curves for rGalD-D and mutant enzymes derived
and determined the melting temperatures (Tm). All 5 enzymes
showed typical melting curve proﬁles (Fig. 4). The Tm values
obtained are shown in Table 3. Introduction of mutations H345F
and H379F caused a decrease of 9 C in Tm values whereas muta-
tion E447N lowered the Tm by 3.5 C. Interestingly, the E532Q
mutant enzyme showed 2 distinct melting temperatures, the ﬁrstTable 3
Melting temperatures (Tm) determined with the thermal shift assay. The melting
temperature (Tm) represents the temperature at which 50% of the protein is unfolded
[21].
Enzyme Tm (C) Tm (C)
rGalD-D 64.3 ± 0.3 –
rGalD-D H379F 55.7 ± 0.3 –
rGalD-D H345F 55.2 ± 0.3 –
rGalD-D E447N 60.8 ± 0.3 –
rGalD-D E532Q 54.7 ± 0.3 64.8 ± 0.3one is 10 C lower than the Tm value for rGalD-D, the second one
being equal to the Tm value for rGalD-D. This observation was only
made for mutant E532Q and may be explained by successive melt-
ing of independent protein domains caused by the mutation
E532Q. From these results we conclude that the mutant proteins
were properly folded, however, introduction of point mutants in
and close to the active site somewhat decreased the thermal stabil-
ity of the proteins.
In conclusion, active site residues in the B. circulans b-galactosi-
dase essential for catalysis and activity have been identiﬁed. Such
information is of prime importance for our future attempts to
change enzyme properties. Our current work provides a ﬁrm basis
for enzyme engineering to further investigate the reaction
mechanism.Author contributions
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